A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Avanir Pharmaceuticals

About Avanir Pharmaceuticals:

AVANIR PHARMACEUTICALS is a publicly held California corporation (AVN) formed in 1988 and publicly traded since 1990. The company was formed to develop and commercialize novel therapeutic products for the treatment of chronic diseases.

Avanir's first product, Abreva(R) is a topical treatment for cold sores.

The company's lead product candidate is Neurodex(TM), for the treatment of pseudobulbar affect (also known as emotional lability) in neurodegenerative diseases. Other potential indications for this product include neuropathic pain, chronic cough and weaning drug dependent patients from narcotics and anti-depressants.

Preclinical programs are currently ongoing in the areas of atherosclerosis and inflammation. Other areas of development include their patented fully human monoclonal antibody technology.


Pipeline Chart for Avanir



NeurodexPseudobulbar Affect
NeurodexNeuropathic Pain


More on Avanir Pharmaceuticals

Home Page

Key Statistics fo Avanir

Basic Chart for Avanir

Analyst Opinion

Analysts Estimates

Headline News

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.